VERFAHREN ZUR HERSTELLUNG VON KREBSVAKZINEN

Cancer vaccines are obtained by treating tumour cells or fibroblasts with a complex of DNA coding for an immunostimulating polypeptide, and of a DNA-binding substance, e.g. polylysine, which is preferably conjugated with transferrin. The complex also contains a conjugate of DNA-binding substance and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	COTTEN MATTHEW DR, ZATLOUKAL KURT DR, SCHMIDT WALTER DR, BIRNSTIEL MAX L. DR, WAGNER ERNST DR
Format:	Patent
Sprache:	ger
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR COMPOSITIONS THEREOF CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES OF PREPARING SUCH COMPOSITIONS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Cancer vaccines are obtained by treating tumour cells or fibroblasts with a complex of DNA coding for an immunostimulating polypeptide, and of a DNA-binding substance, e.g. polylysine, which is preferably conjugated with transferrin. The complex also contains a conjugate of DNA-binding substance and an adenovirus. The adenovirus has at least one E4 defect or one E1a defect in combination with other gene defects.